MDXH — MDxHealth SA Cashflow Statement
0.000.00%
Last trade - 00:00- $164.33m
- $220.22m
- $90.05m
- 25
- 45
- 61
- 39
Annual cashflow statement for MDxHealth SA, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | C2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -27.1 | -26.8 | -37.9 | -27.3 | -24.7 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 1.57 | 1.22 | 0.911 | 0.665 | 1.73 |
| Unusual Items | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | 1.98 | 0.035 | -2.04 | -1.69 | -3.57 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Accounts Payable | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | -20.2 | -22.5 | -34.1 | -21.5 | -18.5 |
| Capital Expenditures | -0.537 | -0.896 | -4.16 | -5.02 | -2.16 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | — | 0 | -25 | 1.09 | 0.523 |
| Acquisition of Business | |||||
| Sale of Business | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | -0.537 | -0.896 | -29.2 | -3.93 | -1.64 |
| Financing Cash Flow Items | -1.07 | -1 | -1.29 | -4.05 | -7.73 |
| Other Financing Cash Flow | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 14.3 | 66.5 | 20.8 | 32.3 | 44.6 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | -6.1 | 42.5 | -43 | 6.88 | 24.4 |